This is Moderna's Canada website
It may contain content that is not applicable to your location
Welcome to the LNP Suite
Our platform enables rapid design, research and testing of multiple mRNAs, within days. Our novel production methods allow us to get medicines to more people, faster.
Drug delivery technology customizable to specific mRNA modalities
mRNA-LNP encapsulation to assist with drug delivery to targeted cells
Protection of mRNA from premature degradation during transport to the targeted site in the body
mRNA platform allows for rapid scale-up and short turnaround times for the manufacturing of new drug substances between batches
Our platform technology allows for productive manufacturing at scale
mRNA vaccines and therapeutics are built using the same process, same equipment, same people, and 95% of the same raw materials—making it possible to deliver with speed, scale, and flexibility.
Speed
Our platform allows for accelerated research and development timelines, and rapid iteration cycles.
Flexibility
mRNA vaccines and mRNA therapeutics can be produced in the same factory via the same cell-free manufacturing process.
Scale
Our platform enables large quantities of medicines to be rapidly produced.
